ÂÜÀòÂÒÂ×

Dr. Naruhito Higo serves as Noven’s Chairman and Chief Executive Officer. He has been with Hisamitsu Pharmaceutical Co., Inc. since 1985, and served as the Head of Research and Development from 2007 to 2017. Dr. Higo has been a member of Hisamitsu’s Board of Directors since 2012 and was appointed as Chairman of Noven’s Board of Directors in 2017. Dr. Higo earned his PhD in Pharmaceutical Science from Kumamoto University in Japan. His rich history with Hisamitsu, his role as Chairman of the Board for Noven, and his vision for future Noven/Hisamitsu strategy position him as an ideal choice to lead Noven in advancing our mission of benefiting patients around the world with transdermal drug delivery systems.